Stockholders' Equity

6 Months Ended

Sep. 30, 2022

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders' EquityStock Repurchase Program. The Company's Board of Directors has approved various authorizations under the Company's stock repurchase program to repurchase shares of its common stock, including a July 27, 2022 approval to increase its stock repurchase authorization by $1,200,000, (collectively, the stock repurchase program). The stock repurchase program does not obligate the Company to acquire any amount of common stock and may be suspended at any time at the Company's discretion. As of September 30, 2022, the aggregate remaining approved amount under the stock repurchase program is $1,503,767.

Stock repurchase activity under the Company's stock repurchase program during the six months ended September 30, 2022, was as follows:

	Amounts
Total number of shares repurchased*	557,675
Weighted average price paid per share	$	269.41
Dollar value of shares repurchased**	$	150,240

*All share repurchases were made pursuant to our publicly announced stock repurchase program in open-market transactions.

** May not calculate on rounded dollars.

Subsequent to September 30, 2022, through October 13, 2022, the Company repurchased 15,002 shares at a weighted average price of $333.21 per share for $4,999 and had $1,498,768 remaining authorized under the stock repurchase program.

Accumulated Other Comprehensive Loss. The components within AOCL, net of tax, recorded in the condensed consolidated balance sheets are as follows:

	September 30, 2022		March 31, 2022
Unrealized gain on cash flow hedges	$	1,846	$	—
Cumulative foreign currency translation loss	(54,208)		(24,955)
Total	$	(52,362)	$	(24,955)